- China-based healthcare products and services provider, BIMI International Medical Inc BIMI, reported Q3 sales of $13.78 million from $3.09 million a year ago.
- The Company said that the growth was mainly driven by the increase in sales of wholesale pharmaceuticals and the recently-acquired five hospitals.
- Revenues from the wholesale pharmaceuticals segment reached $8.4 million. Sales from the medical devices segment reached $1.61 million, and the services segment generated sales of $2.9 million.
- The gross profit increased to $2.03 million from $257k reported a year ago.
- BIMI reported a Q3 EPS loss of $(0.06) narrower than $(0.19) posted a year ago.
- BIMI held cash of $209k and working capital of $2.12 million.
- Price Action: BIMI shares are up 63.9% at $1.07 during the premarket session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
